Valley National Advisers’s iBio IBIO Stock Holding History

Valley National Advisers’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4	Closed	-$4K	–	825
2020 Q3	$4K	Buy	4 +2	+100%	+$2.9K	﹤0.01%	589
2020 Q2	$2K	Buy	+2	New	+$1.31K	﹤0.01%	665

Other funds holding IBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Valley National Advisers's IBIO Position: Q4 2020 in Review

Valley National Advisers sold out of iBio (IBIO) in Q4 2020, closing a stake of 4 shares — an estimated $4K sold.

Valley National Advisers first reported a position in IBIO in Q2 2020 and held it in 2 quarters. The position peaked at $4K in Q3 2020. 89 funds tracked by Wall St. Rank hold IBIO as of Q4 2020.

Valley National Advisers reported no remaining iBio position as of Q4 2020 after selling out during the quarter.
Valley National Advisers sold 4 iBio shares in Q4 2020, an estimated $4K.
Valley National Advisers first reported a position in iBio in Q2 2020 and held it in 2 quarters.
Valley National Advisers's iBio position peaked at $4K in Q3 2020.
89 funds tracked by Wall St. Rank held iBio as of Q4 2020.

Based on Valley National Advisers's 13F filing for Q4 2020, filed 11 Feb 2021.